Logo image of IVDA

IVEDA SOLUTIONS INC (IVDA) Stock Fundamental Analysis

NASDAQ:IVDA - Nasdaq - US46583A3032 - Common Stock - Currency: USD

3.25  -0.38 (-10.47%)

After market: 3.1982 -0.05 (-1.59%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IVDA. IVDA was compared to 284 industry peers in the Software industry. IVDA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IVDA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVDA has reported negative net income.
IVDA had a negative operating cash flow in the past year.
In the past 5 years IVDA always reported negative net income.
IVDA had negative operating cash flow in 4 of the past 5 years.
IVDA Yearly Net Income VS EBIT VS OCF VS FCFIVDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2019 2020 2021 2022 2023 0 -1M -2M -3M -4M -5M

1.2 Ratios

IVDA has a Return On Assets of -35.93%. This is amonst the worse of the industry: IVDA underperforms 81.23% of its industry peers.
IVDA has a worse Return On Equity (-57.49%) than 70.40% of its industry peers.
Industry RankSector Rank
ROA -35.93%
ROE -57.49%
ROIC N/A
ROA(3y)-59.62%
ROA(5y)-73.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVDA Yearly ROA, ROE, ROICIVDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2019 2020 2021 2022 2023 0 200 400

1.3 Margins

The Gross Margin of IVDA (23.59%) is worse than 83.75% of its industry peers.
In the last couple of years the Gross Margin of IVDA has declined.
IVDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.82%
GM growth 5YN/A
IVDA Yearly Profit, Operating, Gross MarginsIVDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

IVDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVDA has less shares outstanding than it did 1 year ago.
IVDA has a better debt/assets ratio than last year.
IVDA Yearly Shares OutstandingIVDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2019 2020 2021 2022 2023 5M 10M 15M
IVDA Yearly Total Debt VS Total AssetsIVDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2019 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

IVDA has an Altman-Z score of -6.09. This is a bad value and indicates that IVDA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.09, IVDA is doing worse than 86.64% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that IVDA is not too dependend on debt financing.
IVDA has a Debt to Equity ratio of 0.12. This is comparable to the rest of the industry: IVDA outperforms 49.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -6.09
ROIC/WACCN/A
WACC10.7%
IVDA Yearly LT Debt VS Equity VS FCFIVDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 2.45 indicates that IVDA has no problem at all paying its short term obligations.
IVDA's Current ratio of 2.45 is fine compared to the rest of the industry. IVDA outperforms 68.59% of its industry peers.
IVDA has a Quick Ratio of 2.04. This indicates that IVDA is financially healthy and has no problem in meeting its short term obligations.
IVDA's Quick ratio of 2.04 is fine compared to the rest of the industry. IVDA outperforms 61.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.04
IVDA Yearly Current Assets VS Current LiabilitesIVDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for IVDA have decreased strongly by -700.52% in the last year.
Looking at the last year, IVDA shows a very negative growth in Revenue. The Revenue has decreased by -30.10% in the last year.
Measured over the past years, IVDA shows a very strong growth in Revenue. The Revenue has been growing by 63.73% on average per year.
EPS 1Y (TTM)-700.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-424.76%
Revenue 1Y (TTM)-30.1%
Revenue growth 3Y63.73%
Revenue growth 5YN/A
Sales Q2Q%175.65%

3.2 Future

The Earnings Per Share is expected to grow by 47.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, IVDA will show a very strong growth in Revenue. The Revenue will grow by 80.75% on average per year.
EPS Next Y89.26%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.96%
Revenue Next 2Y80.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVDA Yearly Revenue VS EstimatesIVDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IVDA Yearly EPS VS EstimatesIVDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

IVDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 13.85 indicates a correct valuation of IVDA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IVDA indicates a rather cheap valuation: IVDA is cheaper than 88.09% of the companies listed in the same industry.
IVDA is valuated cheaply when we compare the Price/Forward Earnings ratio to 95.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 13.85
IVDA Price Earnings VS Forward Price EarningsIVDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVDA Per share dataIVDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IVDA's earnings are expected to grow with 47.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.53%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IVEDA SOLUTIONS INC

NASDAQ:IVDA (2/5/2025, 8:08:06 PM)

After market: 3.1982 -0.05 (-1.59%)

3.25

-0.38 (-10.47%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners3.01%
Inst Owner Change0.06%
Ins Owners5.89%
Ins Owner Change0%
Market Cap8.64M
Analysts82.86
Price Target8.16 (151.08%)
Short Float %4.98%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.9%
Min Revenue beat(2)-39.84%
Max Revenue beat(2)-5.95%
Revenue beat(4)0
Avg Revenue beat(4)-47.95%
Min Revenue beat(4)-86.43%
Max Revenue beat(4)-5.95%
Revenue beat(8)1
Avg Revenue beat(8)-35.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.85
P/S 1.63
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 1.91
EV/EBITDA N/A
EPS(TTM)-1.33
EYN/A
EPS(NY)0.23
Fwd EY7.22%
FCF(TTM)-1.7
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS1.99
BVpS2.13
TBVpS1.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.93%
ROE -57.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.59%
FCFM N/A
ROA(3y)-59.62%
ROA(5y)-73.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.82%
GM growth 5YN/A
F-Score2
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2462.56%
Cap/Sales 10.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 2.04
Altman-Z -6.09
F-Score2
WACC10.7%
ROIC/WACCN/A
Cap/Depr(3y)1532.21%
Cap/Depr(5y)932.66%
Cap/Sales(3y)4.93%
Cap/Sales(5y)3.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-700.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-424.76%
EPS Next Y89.26%
EPS Next 2Y47.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.1%
Revenue growth 3Y63.73%
Revenue growth 5YN/A
Sales Q2Q%175.65%
Revenue Next Year-0.96%
Revenue Next 2Y80.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.71%
OCF growth 3YN/A
OCF growth 5YN/A